Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines
Authors:
- Kl GlazenburgKGKl Glazenburg
- Ml van VeenMVMl van Veen
- Mmj KraakMKMmj Kraak
- Gap HospersGHGap Hospers
- S StörkelSSS Störkel
- Ege de VriesEVEge de Vries
- J WilschutJWJ Wilschut
- T DaemenTDT Daemen
- 1 October 2001
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (20) , 1515-1523
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 46 references indexed in Scilit:
- Activation of peritoneal cells upon in vivo transfection with a recombinant alphavirus expressing GM-CSFGene Therapy, 2001
- Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7Gene Therapy, 2000
- Immunological Gene Therapy with ex Vivo Gene-Modified Tumor Cells: A Critique and a ReappraisalHuman Gene Therapy, 2000
- Immunotherapy of CancerAnnals of the New York Academy of Sciences, 1999
- Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A geneGene Therapy, 1999
- Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonographyGene Therapy, 1999
- Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cellsGene Therapy, 1997
- Cytokine Gene Therapy of Cancer Using Interleukin‐12: Murine and Clinical TrialsAnnals of the New York Academy of Sciences, 1996
- Antitumor effect induced by granulocyte/macrophage-colony-stimulating factor gene-modified tumor vaccination: Comparison of adenovirus- and retrovirus-mediated genetic transductionJournal of Cancer Research and Clinical Oncology, 1995
- Phase I Study of Non-Replicating Autologous Tumor Cell Injections Using Cells Prepared With or Without GM-CSF Gene Transduction in Patients with Metastatic Renal Cell Carcinoma. Johns Hopkins Oncology Center, Baltimore, MarylandHuman Gene Therapy, 1995